Diets
intermittent fasting is-non-inferior-to continuous calorie restriction for glycemic control
In plain terms: Is 5:2-style intermittent fasting as good as everyday calorie-cutting for HbA1c and weight in type 2 diabetes?
Part of: 🥗 intermittent fasting
Yes — head-to-head randomized non-inferiority trials show 5:2/intermittent energy restriction matches daily calorie restriction for HbA1c and weight loss, so it is a reasonable equivalent option, not a superior one.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Li H et al 2026 · study_type: meta-analysis | meta-analysis | supports | moderate | SR/MA 9 RCTs (n=894) IF vs CER in MASLD: no significant between-group difference on glucose indices (IF favored only on weight/BMI/LDL). Consistent with glycemic non-inferiority; scope=MASLD not diagnosed T2D. |
| Khalafi 2024 · Diabetes Obes Metab | meta-analysis | mixed | moderate | Meta-analysis in prediabetes/T2D found intermittent fasting improved body composition/cardiometabolic markers similarly to calorie restriction, not clearly superior. |
| Lakhani 2025 · Prim Care Diabetes | observational | mixed | low | Review notes IF gives strong short-term HbA1c and weight benefits comparable to continuous restriction but with weaker long-term durability and adherence data. |
| Vitale 2020 · Metab Syndr Relat Disord | meta-analysis | mixed | low | Systematic review of RCTs found intermittent fasting improved glycemic indices/body composition in T2D but evidence base was small and heterogeneous. |
| Borgundvaag 2021 · J Clin Endocrinol Metab | meta-analysis | supports | moderate | Meta-analysis of interventional studies found intermittent fasting reduced HbA1c and weight in T2D comparably to standard energy restriction. |
| Semnani-Azad 2025 2025 · BMJ | meta-analysis | supports | high | Network meta-analysis of RCTs: intermittent fasting produced small added weight/cardiometabolic benefit vs continuous energy restriction but effects were modest and largely comparable. ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
| Wang 2021 · Diabetes Res Clin Pract | meta-analysis | supports | moderate | Meta-analysis of RCTs found IF and continuous energy-restricted diets produced similar glycemic control and weight loss in type 2 diabetes / metabolic syndrome. |
| Carter 2018 · JAMA Netw Open | RCT | supports | high | In a 12-month randomized non-inferiority trial in type 2 diabetes, two-day-per-week intermittent energy restriction was non-inferior to continuous restriction for HbA1c and weight change. ↩ SUPERSEDED — pooled in the review above, counted once |
| Carter 2019 · Diabetes Res Clin Pract | RCT | supports | moderate | 24-month follow-up confirmed intermittent and continuous energy restriction produced comparable long-term glycemic control, with adherence declining in both arms. |
| Dietvorst 2026 · Clin Nutr ESPEN | RCT | mixed | moderate | 3-month RCT found intermittent and continuous calorie restriction produced similar body-composition and resting-energy-expenditure changes in T2D. |
| Schroor 2024 · Adv Nutr | meta-analysis | supports | high | Meta-analysis of 28 trials found intermittent energy restriction and continuous restriction yielded comparable body-weight and cardiometabolic outcomes. |
| Al Qudah 2026 · Front Nutr | meta-analysis | tested-null | low | Meta-analysis found intermittent fasting improved HbA1c and weight in oral-therapy-treated but not insulin-treated T2D patients. |
| Carter 2016 · Diabetes Res Clin Pract | RCT | supports | moderate | Pragmatic pilot RCT found 2-day intermittent (5:2-style) restriction produced HbA1c and weight changes equivalent to continuous restriction in T2D. ↩ SUPERSEDED — pooled in the review above, counted once |
| Abdollahpour N et al 2025 · study_type: observational | observational | supports | low | Cohort n=82, 5:2 vs daily CR in overweight/obese: glycemic markers similar between groups (IF differed only on BP/TG/CVD-risk). Underpowered but consistent with non-inferiority. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.